An adjuvant-containing cDC1-targeted recombinant fusion vaccine conveys strong protection against murine melanoma growth and metastasis
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - August 25, 2022 Category: Cancer & Oncology Authors: Mohammad Arabpour Sanchari Paul Hanna Grauers Wiktorin Mustafa Kaya Roberta Kiffin Nils Lycke Kristoffer Hellstrand Anna Martner Source Type: research

scRNA-seq reveals ATPIF1 activity in control of T cell antitumor activity
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - August 21, 2022 Category: Cancer & Oncology Authors: Genshen Zhong Qi Wang Ying Wang Ying Guo Meiqi Xu Yaya Guan Xiaoying Zhang Minna Wu Zhishan Xu Weidong Zhao Hongkai Lian Hui Wang Jianping Ye Source Type: research

A T-cell engaging bispecific antibody with a tumor-selective bivalent folate receptor alpha binding arm for the treatment of ovarian cancer
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - August 21, 2022 Category: Cancer & Oncology Authors: Brian C. Avanzino Kirthana Prabhakar Pranjali Dalvi Sharon Hartstein Hannes Kehm Aarti Balasubramani Andrew A. Boudreau Ben Buelow Karen Chang Laura M. Davison Suhasini Iyer Vidyut Kalwit Kristin Lewis Wilson Harbani K. Malik-Chaudhry Will Pierson Geovann Source Type: research

Expression of cartilage oligomeric matrix protein in periampullary adenocarcinoma is associated with pancreatobiliary-type morphology, higher levels of fibrosis and immune cell exclusion
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - August 18, 2022 Category: Cancer & Oncology Authors: Konstantinos S. Papadakos Sebastian Lundgren Chrysostomi Gialeli Patrick Micke Artur Mezheyeuski Jacob Elebro Karin Jirstr öm Anna M. Blom Source Type: research

CAR-T Engager proteins optimize anti-CD19 CAR-T cell therapies for lymphoma
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - August 18, 2022 Category: Cancer & Oncology Authors: Lihe Su Lan Wu Roy R. Lobb Paul D. Rennert Christine Ambrose Source Type: research

IFN γ directly counteracts imatinib-induced apoptosis of primary human CD34+ CML stem/progenitor cells potentially through the upregulation of multiple key survival factors
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - August 13, 2022 Category: Cancer & Oncology Authors: Dorina Ujvari Alena Malyukova Ana Zovko Elham Yektaei-Karin Harsha S Madapura Marton Keszei Noemi Nagy Kourosh Lotfi Niclas Bj örn Jonas Wallvik Leif Stenke Daniel Salamon Source Type: research

PARP1 inhibition elicits immune responses against non-small cell lung cancer
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - August 11, 2022 Category: Cancer & Oncology Authors: Pan Juncheng Antoine Lafarge Guido Kroemer Maria Castedo Source Type: research

Synergistic effect of combining sunitinib with a peptide-based vaccine in cancer treatment after microenvironment remodeling
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - August 9, 2022 Category: Cancer & Oncology Authors: Alice Mougel Fanny M éjean Thi Tran Yasmine Adimi Isabelle Galy-Fauroux Christelle Kabor é Erwan Mercier Pauline Urquia Magali Terme Eric Tartour Corinne Tanchot Source Type: research

Schweinfurthin induces ICD without ER stress and caspase activation
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - August 3, 2022 Category: Cancer & Oncology Authors: Ruoheng Zhang J.D. Neighbors T.D. Schell R.J. Hohl Source Type: research

The MICA-NKG2D axis in clear cell renal cell carcinoma bolsters MICA as target in immuno-oncology
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - August 3, 2022 Category: Cancer & Oncology Authors: Florencia Secchiari Sol Yanel Nu ñez Jessica Mariel Sierra Andrea Ziblat Mar ía Victoria Regge Ximena Luc ía Raffo Iraolagoitia Agust ín Rovegno Carlos Ameri Fernando Pablo Secin Nicol ás Richards Hernando R íos Pita Gonzalo Vitagliano Luis Rico Mau Source Type: research

Targeting 3D chromosomal architecture at the RANK loci to suppress myeloma-driven osteoclastogenesis
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - August 1, 2022 Category: Cancer & Oncology Authors: Katja Th ümmler Mark TS Williams Susan Kitson Shatakshi Sood Moeed Akbar John J Cole Ewan Hunter Richard Soutar Carl S Goodyear Source Type: research

Enriched circulating and tumor-resident TGF- β+ regulatory B cells in patients with melanoma promote FOXP3+ Tregs
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - July 28, 2022 Category: Cancer & Oncology Authors: Robert J Harris Zena Willsmore Roman Laddach Silvia Crescioli Jitesh Chauhan Anthony Cheung Anna Black Jenny L. C. Geh Alastair D MacKenzie Ross Ciaran Healy Sophia Tsoka James Spicer Katie E Lacy Sophia N Karagiannis Source Type: research

One cisplatin dose provides durable stimulation of anti-tumor immunity and alleviates anti-PD-1 resistance in an intraductal model for triple-negative breast cancer
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - July 23, 2022 Category: Cancer & Oncology Authors: Jonas Steenbrugge Julie Bellemans Niels Vander Elst Kristel Demeyere Josephine De Vliegher Timothy Perera Olivier De Wever Wim Van Den Broeck Ward De Spiegelaere Niek N. Sanders Evelyne Meyer Source Type: research

Peripheral gene signatures reveal distinct cancer patient immunotypes with therapeutic implications for autologous DC-based vaccines
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - July 23, 2022 Category: Cancer & Oncology Authors: Michal Hensler Jana Rakova Lenka Kasikova Tereza Lanickova Josef Pasulka Peter Holicek Marek Hraska Tereza Hrnciarova Pavla Kadlecova Andreu Schoenenberger Klara Sochorova Daniela Rozkova Ludek Sojka Jana Drozenova Jan Laco Rudolf Horvath Michal Podrazil Source Type: research

Targeting stearoyl-coa desaturase enhances radiation induced ferroptosis and immunogenic cell death in esophageal squamous cell carcinoma
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - July 16, 2022 Category: Cancer & Oncology Authors: Hui Luo Xiaohui Wang Shuai Song Yunhan Wang Qinfu Dan Hong Ge Source Type: research